Browse > Article
http://dx.doi.org/10.14253/kjcn.2015.17.1.24

Myeloma-associated Amyloidosis Presenting as Orthostatic Intolerance  

Jeong, Heejeong (Department of Neurology, Institute of Health Science, Gyeongsang National University School of Medicine)
Nam, Wonsik (Department of Neurology, Institute of Health Science, Gyeongsang National University School of Medicine)
Son, Seungnam (Department of Neurology, Institute of Health Science, Gyeongsang National University School of Medicine)
Kim, Soo-Kyung (Department of Neurology, Institute of Health Science, Gyeongsang National University School of Medicine)
Kang, Heeyoung (Department of Neurology, Institute of Health Science, Gyeongsang National University School of Medicine)
Choi, Nack-Cheon (Department of Neurology, Institute of Health Science, Gyeongsang National University School of Medicine)
Kwon, Oh-Young (Department of Neurology, Institute of Health Science, Gyeongsang National University School of Medicine)
Lim, ByeongHoon (Department of Neurology, Institute of Health Science, Gyeongsang National University School of Medicine)
Park, Ki-Jong (Department of Neurology, Institute of Health Science, Gyeongsang National University School of Medicine)
Publication Information
Annals of Clinical Neurophysiology / v.17, no.1, 2015 , pp. 24-27 More about this Journal
Abstract
Amyloidosis is a systemic disorder associated with clonal plasma cell dyscrasia. Nephrotic syndrome, congestive heart failure, autonomic and peripheral neuropathy is often associated features in amyloidosis. Early diagnosis is most important because of different prognosis by stage. The diagnosis can be delayed since symptoms of amyloidosis may vary or nonspecific. We describe a patient of myeloma-associated amyloidosis, who showed orthostatic intolerance as the first symptom of the disease.
Keywords
Orthostatic intolerance; Amyloidosis; Neuropathy;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hawkins PN. Amyloidosis. Blood Rev 1995;9:135-142.   DOI
2 Wang AK, Fealey RD, Gehrking TL, Low PA. Patterns of neuropathy and autonomic failure in patients with amyloidosis. Mayo Clin Proc 2008;83:1226-1230.   DOI
3 Duston MA, Skinner M, Anderson J, Cohen AS. Peripheral neuropathy as an early marker of AL amyloidosis. Arch Intern Med 1989;149:358-360.   DOI
4 Low, A. P, Benarroch, E. E. Cinical autonomic disorders. In. Baltimore: Williams & Wilkins, 2008:387.
5 Mahmood S, Palladini G, Sanchorawala V, Wechalekar A. Update on treatment of light chain amyloidosis. Haematologica 2014;99:209-221.   DOI
6 Kumar S, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Colby C, et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol 2012;30:989-995.   DOI
7 Chan J, Sangwaiya A, Arnold J. Amyloid light-chain amyloidosis, myeloma and autonomic neuropathy. Grand Rounds 2011;11:56-59.   DOI
8 No author list. Assessment: Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1996;46:873-880.